At the starting dose, it lasts only two weeks, which is less than ideal
Its a small trial with only 1-year follow up and lacking hard endpoints such as hospitalization or cardiovascular deaths, but the results for symptomatic relief and gain in physical activity are certainly very encouraging
The hexosamine pathway is activated by high blood sugar levels, which causes damage to Schwann cells and nerve cells through inflammation and oxidative stress, eventually leading to diabetic peripheral neuropathy (DPN)
If the color changes during use, you can compare against your original photo under similar lighting
doi: 10.1016/j.lfs.2020.118731 166 AbdallaMADeshmukhHAtkinSSathyapalanT
Using 90471 on a Medicare Part B claim results in a denial, so the two are not interchangeable